| 标题 |
Discovery of 2-[3,5-Dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor β Agonist in Clinical Trials for the Treatment of Dyslipidemia |
| 备注 |
需要正文以及补充材料
💡 该求助存在备注,如果存在信息冲突,请以备注为准
|
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of Medicinal Chemistry 作者:Martha J. Kelly; Sherrie Pietranico-Cole; J. Douglas Larigan; Nancy-Ellen Haynes; Charles H. Reynolds; et al 出版日期:2014-04-08 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)